Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEurocell Regulatory News (ECEL)

Share Price Information for Eurocell (ECEL)

Share Price is delayed by 15 minutes
Get Live Data
107.50    -1.50 (-1.38%)
Bid:
105.00
Ask:
107.00
Spread: 2.00 (1.905%)
Market Cap: £105.94m
ECEL Live PriceLast checked at - London Stock Exchange

Intraday Eurocell Share Chart

Auditor Resignation

20 Jun 2025 07:00

RNS Number : 6420N
Eurocell plc
20 June 2025
 

EUROCELL PLC

("Eurocell" or the "Company")

Auditor Resignation

In accordance with section 520(2) of the Companies Act 2006 (the "Act"), Eurocell plc (the "Company"), announces, that as resolved at the Company's Annual General Meeting on 15 May 2025 ("AGM 2025") and following the competitive audit tender process undertaken by the Company during 2024, it has received a statutory statement from PricewaterhouseCoopers ("PwC") in connection with their resignation as auditors of the Company.

 

The resignation of PwC took effect at the conclusion of the AGM 2025.

 

As resolved at the AGM 2025, following the outcome of the competitive audit tender process, the Company has confirmed the appointment of Deloitte LLP as auditor for the financial year ending 31 December 2025. 

 

As required by Section 520(2) of the Companies Act 2006, a copy of PwC's reason for resignation, being the outcome of the competitive audit tender process, is being sent to shareholders for information only and will also be uploaded to the National Storage Mechanism. It will shortly be available for inspection at  https://data.fca.org.uk/#/nsm/ nationalstoragemechanism.

 

There are no other matters connected with PwC's ceasing to hold office that are required to be brought to the attention of the members or creditors of the Company for the purposes of section 519 of the Act.

 

Enquiries:

 

Eurocell plc

Vicky Williams

Group Company Secretary

Tel: 01773 842100

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUKVSRVOUNAAR
Date   Source Headline
21st Jul 20163:12 pmRNSHolding(s) in Company
30th Jun 20167:00 amRNSAwards to Directors and PDMRs
19th May 20162:43 pmRNSResult of AGM
19th May 20167:00 amRNSAGM Trading Update
21st Apr 20166:04 pmRNSHolding(s) in Company
20th Apr 20167:00 amRNSResult of Placing
19th Apr 20164:36 pmRNSProposed Placing
7th Apr 20163:58 pmRNSConfirmation of CEO Board Change
16th Mar 20167:00 amRNS2015 Full Year Results
9th Mar 20167:00 amRNSAcquisition
26th Jan 20167:04 amRNSDirectorate Change
21st Jan 20167:00 amRNSTrading Statement
1st Dec 20153:06 pmRNSHolding(s) in Company
11th Nov 201510:56 amRNSDirector Declaration
18th Sep 20159:56 amRNSHolding(s) in Company
17th Sep 201511:31 amRNSHolding(s) in Company
17th Sep 201511:29 amRNSHolding(s) in Company
15th Sep 201511:06 amRNSResult of Placing
15th Sep 20157:00 amRNSProposed Placing
25th Aug 20157:00 amRNSHalf Yearly Results
29th May 20152:59 pmRNSChange of Adviser
13th May 20155:32 pmRNSHolding(s) in Company
14th Apr 20157:00 amRNSAppointment of Joint Corporate Brokers
11th Mar 20154:33 pmRNSHolding(s) in Company
11th Mar 20153:17 pmRNSHolding(s) in Company
10th Mar 20157:03 amRNSAnnouncement of Grant Awards
9th Mar 20158:00 amRNSAdmission to Trading on London Stock Exchange
4th Mar 20152:31 pmRNSPublication of Prospectus
4th Mar 20157:00 amRNSAnnouncement of Offer Price

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.